Literature DB >> 17977494

Risks of statin use during pregnancy: a systematic review.

Aleksey Kazmin1, Facundo Garcia-Bournissen1, Gideon Koren1.   

Abstract

Although statins have been identified as potential teratogens on the basis of theoretical considerations and small case series, the available evidence is far from conclusive. In fact, epidemiological data collected to date suggest that statins are not major teratogens. The actual risk for an exposed pregnancy seems to be small, if present at all, and does not by itself warrant termination of pregnancy. Nevertheless, given the scarcity of available data, it is still advisable to avoid use of these drugs in patients who are planning pregnancy in order to reduce the risks as much as possible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977494     DOI: 10.1016/S1701-2163(16)32656-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  23 in total

1.  The early developments of preeclampsia drugs.

Authors:  Maged M Costantine; Cande V Ananth
Journal:  Expert Opin Investig Drugs       Date:  2016-06-16       Impact factor: 6.206

Review 2.  Type 2 diabetes in pregnancy: importance of optimized care before, during and after pregnancy.

Authors:  E Keely
Journal:  Obstet Med       Date:  2008-12-01

Review 3.  Coronary heart disease in young adults.

Authors:  Jessica B Rubin; William B Borden
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

Review 4.  Can we dramatically reduce the incidence of coronary heart disease?

Authors:  Michael Domanski; Donald Lloyd-Jones; Valentin Fuster; Scott Grundy
Journal:  Nat Rev Cardiol       Date:  2011-11-01       Impact factor: 32.419

5.  Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?

Authors:  Caroline C Marrs; Maged M Costantine
Journal:  Clin Obstet Gynecol       Date:  2017-03       Impact factor: 2.190

6.  Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.

Authors:  Chandra K Singh; Ambrish Kumar; David B Hitchcock; Daping Fan; Richard Goodwin; Holly A LaVoie; Prakash Nagarkatti; Donald J DiPette; Ugra S Singh
Journal:  Mol Nutr Food Res       Date:  2011-01-20       Impact factor: 5.914

Review 7.  Challenges in conducting clinical research studies in pregnant women.

Authors:  Monique McKiever; Heather Frey; Maged M Costantine
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-04-18       Impact factor: 2.745

8.  Acute coronary syndrome in pregnancy.

Authors:  Douglas Wright; Claire Kenny-Scherber; Alison Montgomery; Omid Salehian
Journal:  Clin Med Cardiol       Date:  2009-12-08

9.  Simvastatin and dipentyl phthalate lower ex vivo testicular testosterone production and exhibit additive effects on testicular testosterone and gene expression via distinct mechanistic pathways in the fetal rat.

Authors:  Brandiese E J Beverly; Christy S Lambright; Johnathan R Furr; Hunter Sampson; Vickie S Wilson; Barry S McIntyre; Paul M D Foster; Gregory Travlos; L Earl Gray
Journal:  Toxicol Sci       Date:  2014-07-23       Impact factor: 4.849

Review 10.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.